INTECH Investment Management’s Puma Biotechnology PBYI Stock Holding History

INTECH Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.8K	Buy	+10,210	New	+$74.8K	﹤0.01%	1980
2026 Q1	–	Sell	-18,900	Closed	-$112K	–	2293
2025 Q4	$112K	Hold	18,900	–	–	﹤0.01%	2135
2025 Q3	$100K	Sell	18,900 -1,923	-9%	-$8.15K	﹤0.01%	2264
2025 Q2	$71.4K	Sell	20,823 -9,681	-32%	-$30.9K	﹤0.01%	2364
2025 Q1	$90.3K	Buy	30,504 +10,474	+52%	+$32.8K	﹤0.01%	2339
2024 Q4	$61.1K	Buy	+20,030	New	+$58.3K	﹤0.01%	2305

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's PBYI Position: Q2 2026 in Review

INTECH Investment Management opened a new position in Puma Biotechnology (PBYI) in Q2 2026: 10,210 shares worth $82.8K. The stake represents ﹤0.01% of the portfolio and ranks #1980 among its holdings. This is a return to the name: INTECH Investment Management previously reported a position in PBYI as recently as Q4 2025.

INTECH Investment Management first reported a position in PBYI in Q4 2024 and has held it in 6 quarters since. The position peaked at $112K in Q4 2025. 160 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

INTECH Investment Management held 10,210 shares of Puma Biotechnology worth $82.8K as of Q2 2026.
Puma Biotechnology was a new INTECH Investment Management position in Q2 2026.
Puma Biotechnology made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1980 holding.
INTECH Investment Management first reported a position in Puma Biotechnology in Q4 2024 and has held it in 6 quarters since.
INTECH Investment Management's Puma Biotechnology position peaked at $112K in Q4 2025.
160 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.